NCT02401269View on ClinicalTrials.gov

Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Cardiovascular Disease Risk in HIV PatientsEndothelial Function
Interventions
DRUG

Aspirin

DRUG

Placebo

Trial Locations (1)

Unknown

Lighthouse Trust, Lilongwe

All Listed Sponsors
collaborator

Fogarty International Center of the National Institute of Health

NIH

collaborator

University of North Carolina

OTHER

lead

University of Pittsburgh

OTHER

NCT02401269 - Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study | Biotech Hunter | Biotech Hunter